anonymous
Guest
anonymous
Guest
Ok, XR was approved in February and we delayed the launch until May, and now we are hearing that many plans consider XR to be a line extension and are not approving it for patients. Here is my plan to deal with this, I WILL NOT promote XR until the managed care situation is solved. I will ONLY PROMOTE BID Austedo! How do you guys plan to handle this in your territory? Inexcusable that they are asking us to promote a product with the managed care situation being what it is! They have had PLENTY of time to get this right! Neurocrine is foaming at the mouth enjoying every moment of our confusion!